PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32105765 ↗2020Reported benefit

miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats.

RatChemical/toxinSprague-DawleyFemaleTrans-round window niche delivery to the cochleamiR-182 mimics delivered before intraperitoneal kanamycin and furosemide

Model: Ototoxic cochlear outer hair cell loss and permanent deafness induced by intraperitoneal kanamycin plus furosemide

Cochlear overexpression of miR-182 attenuated permanent auditory brainstem response threshold shifts and reduced loss of outer hair cells and stereocilia after kanamycin plus furosemide.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.